Human Periosteum-Derived Stem Cells for Tissue Engineering Applications: The Role of VEGF

Stem Cell Reviews and Reports

Volumn 8, Issue 3, 2012, Pages 882-890

  Ferretti, C ^a   Borsari, V ^b   Falconi, M ^c   Gigante, A ^a   Lazzarini, R ^a   Fini, M ^b   Di Primio, R ^a   Mattioli Belmonte, M ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Bone Regeneration; Flt1; KDR Flk1; MSCs; Periosteum; VEGF

Indexed keywords

ALKALINE PHOSPHATASE; LEUKOCYTE ANTIGEN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR; VEGFA PROTEIN, HUMAN;

ADULT; ADULT STEM CELL; ARTICLE; BONE REGENERATION; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; ENDOTHELIUM CELL; FEMALE; HUMAN; MALE; METABOLISM; PERIOSTEUM; PHENOTYPE; PHYSIOLOGY; TISSUE ENGINEERING;

ADULT; ADULT STEM CELLS; ALKALINE PHOSPHATASE; ANTIGENS, CD; BONE REGENERATION; CELL DIFFERENTIATION; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; PERIOSTEUM; PHENOTYPE; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TISSUE ENGINEERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84865560786     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-012-9374-7     Document Type: Article

References (45)

1. Reyes, M., Lund, T., Lenvik, T., Aguiar, D., Koodie, L., & Verfaillie, C. M. (2001). Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood, 98(9), 2615-2625.
2. Augello, A., Kurth, T. B., & De Bari, C. (2010). Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches. European Cells & Materials, 20(9), 121-133.
3. Pittenger, M. F., Mackay, A. M., Beck, S. C., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284(5411), 143-147.
4. Jiang, Y., Vaessen, B., Lenvik, T., Blackstad, M., Reyes, M., & Verfaillie, C. M. (2002). Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Experimental Hematology, 30(8), 896-904.
5. Antonucci, I., Iezzi, I., Morizio, E., et al. (2009). Isolation of osteogenic progenitors from human amniotic fluid using a single step culture protocol. BMC Biotechnology, 16(9), 9-16.
6. Herdrich, B. J., Lind, R. C., & Liechty, K. W. (2008). Multipotent adult progenitor cells: their role in wound healing and the treatment of dermal wounds. Cytotherapy, 10(6), 543-550.
7. Salvolini, E., Orciani, M., Vignini, A., Mattioli-Belmonte, M., Mazzanti, L., & Di Primio, R. (2010). Skin-derived mesenchymal stem cells (S-MSCs) induce endothelial cell activation by paracrine mechanisms. Experimental Dermatology, 19(9), 848-850.
8. Hass, R., Kasper, C., Bohm, S., & Jacobs, R. (2011). Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Communication and Signaling, 9, 12.
9. Karystinou, A., Dell'Accio, F., Kurth, T. B., et al. (2009). Distinct mesenchymal progenitor cell subsets in the adult human synovium. Rheumatology, 48(9), 1057-1064.
10. Gigante, A., Torcianti, M., Boldrini, E., Manzotti, S., Falcone, G., Greco, F., & Mattioli-Belmonte, M. (2008). Vitamin K and D association stimulates in vitro osteoblast differentiation of fracture site derived human mesenchymal stem cells. Journal of Biological Regulators and Homeostatic Agents, 22(1), 35-44.
11. Choi, Y. S., Noh, S. E., Lim, S. M., et al. (2008). Multipotency and growth characteristic of periosteum-derived progenitor cells for chondrogenic, osteogenic, and adipogenic differentiation. Biotechnology Letters, 30(4), 593-601.
12. De Bari, C., Dell'Accio, F., Vanlauwe, J., et al. (2006). Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis and Rheumatism, 54(4), 1209-1221.
13. Nakahara, H., Dennis, J. E., Bruder, S. P., Haynesworth, S. E., Lennon, D. P., & Caplan, A. I. (1991). In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells. Experimental Cell Research, 195(2), 492-503.
14. Nakahara, H., Bruder, S. P., Goldberg, V. M., & Caplan, A. I. (1990). In vivo osteochondrogenic potential of cultured cells derived from the periosteum. Clinical Orthopaedics and Related Research, 259(10), 223-232.
15. Nakahara, H., Bruder, S. P., Haynesworth, S. E., et al. (1990). Bone and cartilage formation in diffusion chambers by subcultured cells derived from the periosteum. Bone, 11(3), 181-188.
16. Izumi, T., Scully, S. P., Heydemann, A., & Bolander, M. E. (1992). Transforming growth factor beta 1 stimulates type II collagen expression in cultured periosteum-derived cells. Journal of Bone and Mineral Research, 7(1), 115-121.
17. Iwasaki, M., Nakata, K., Nakahara, H., et al. (1993). Transforming growth factor-beta 1 stimulates chondrogenesis and inhibits osteogenesis in high density culture of periosteum-derived cells. Endocrinology, 132(4), 1603-1608.
18. Iwasaki, M., Nakahara, H., Nakase, T., et al. (1994). Bone morphogenetic protein 2 stimulates osteogenesis but does not affect chondrogenesis in osteochondrogenic differentiation of periosteum-derived cells. Journal of Bone and Mineral Research, 9(8), 1195-1204.
19. De Bari, C., Dell'Accio, F., & Luyten, F. P. (2001). Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis and Rheumatism, 44(1), 85-95.
20. Gruber, R., Mayer, C., Bobacz, K., et al. (2001). Effects of cartilage-derived morphogenetic proteins and osteogenic protein-1 on osteochondrogenic differentiation of periosteum-derived cells. Endocrinology, 142(5), 2087-2094.
21. Hanada, K., Solchaga, L. A., Caplan, A. I., et al. (2001). BMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis. Journal of Cellular Biochemistry, 81(2), 284-294.
22. Sakaguchi, Y., Sekiya, I., Yagishita, K., & Muneta, T. (2005). Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis and Rheumatism, 52(8), 2521-2529.
23. Arnsdorf, E. J., Jones, L. M., Carter, D. R., & Jacobs, C. R. (2009). The periosteum as a cellular source for functional tissue engineering. Tissue Engineering. Part A, 15(9), 2637-2642.
24. Zisch, A. H., Lutolf, M. P., & Hubbell, J. A. (2003). Biopolymeric delivery matrices for angiogenic growth factors. Cardiovascular Pathology, 12(6), 295-310.
25. Zhang, G., & Suggs, L. J. (2007). Matrices and scaffolds for drug delivery in vascular tissue engineering. Advanced Drug Delivery Reviews, 59(4-5), 360-373.
26. Reyes, M., Dudek, A., Jahagirdar, B., Koodie, L., Marker, P. H., & Verfaillie, C. M. (2002). Origin of endothelial progenitors in human postnatal bone marrow. Journal of Clinical Investigation, 109(3), 337-346.
27. Pal, R., Hanwate, M., Jan, M., & Totey, S. (2009). Phenotypic and functional comparison of optimum culture conditions for upscaling of bone marrow-derived mesenchymal stem cells. Journal of Tissue Engineering and Regenerative Medicine, 3(3), 163-174.
28. Dominici, M., Le Blank, K., Muller, I., et al. (2006). Minimal Criteria for deifying multipotent mesenchymal stem cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(3), 315-317.
29. Oswald, J., Boxberger, S., Jørgensen, B., et al. (2004). Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells, 22(3), 377-384.
30. Hidaka, C., Cunningham, M. E., Rodeo, S. A., Maher, S. A., & Zhu, W. (2006). Modern biologics used in orthopaedic surgery. Current Opinion in Rheumatology, 18(19), 74-79.
31. Stevenson, S. (1998). Enhancement of fracture healing with autogenous and allogeneic bone grafts. Clinical Orthopaedics, 355(Suppl), S239-S246.
32. Silber, J. S., Anderson, D. G., Daffner, S. D., et al. (2003). Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion. Spine, 28(2), 134-139.
33. Brittberg, M., Lindahl, A., Nilsson, A., Ohlsson, C., Isaksson, O., & Peterson, L. (1994). Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. The New England Journal of Medicine, 331(14), 889-895.
34. Barry, F. P., & Murphy, J. M. (2004). Mesenchymal stem cells: clinical applications and biological characterization. The International Journal of Biochemistry & Cell Biology, 36(4), 568-584.
35. Krampera, M., Pizzolo, G., Aprili, G., & Franchini, M. (2006). Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone, 39(3), 678-83.
36. Gigante, A., Manzotti, S., Bevilacqua, C., Orciani, M., Di Primio, R., & Mattioli-Belmonte, M. (2008). Adult mesenchymal stem cells for bone and cartilage engineering: effect of scaffold materials. European Journal of Histochemistry, 52(3), 169-174.
37. Halfon, S., Abramov, N., Grinblat, B., & Ginis, I. (2011). Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging. Stem Cells and Development, 20(1), 53-66.
38. Mayer, H., Bertram, H., Lindenmaier, W., Korff, T., Weber, H., & Weich, H. (2005). Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. Journal of Cellular Biochemistry, 95(2), 827-839.
39. Nakatsu, M. N., Sainson, R. C., Perez-del-Pulgar, S., Aoto, J. N., Aitkenhead, M., & Taylor, K. L. (2003). VEGF(121) and VEGF(165) regulate blood vessel diameter through vascular endothelial growth factor receptor 2 in an in vitro angiogenesis model. Laboratory Investigation, 83(7), 1873-1885.
40. Colnot, C. I., & Helms, J. A. (2001). DNA molecular analysis of matrix remodeling and angiogenesis during long bone development. Mechanisms of Development, 100(2), 245-250.
41. Tatsuyama, K., Maezawa, Y., Baba, H., Imamura, Y., & Fukuda, M. (2000). Expression of various growth factors for cell proliferation and cytodifferentiation during fracture healing repair of bone. European Journal of Histochemistry, 44(2), 269-278.
42. Hansen-Algenstaedt, N., Joscheck, C., Wolfram, L., et al. (2006). Sequential changes in vessel formation and micro-vascular function during bone repair. Acta Orthopaedica, 77(3), 429-439.
43. Bourke, H. E., Sandison, A., Hughes, S. P. F., & Reichert, I. L. H. (2003). Vascular endothelial growth factor (VEGF) in human periosteum -normal expression and response to fracture. Journal of Bone & Joint Surgery, 85B(1), 4-11.
44. Samee, M., Kasugai, S., Kondo, H., Ohya, K., Shimokawa, H., & Kuroda, S. (2008). Bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) transfection to human periosteal cells enhances osteoblast differentiation and bone formation. Journal of Pharmacological Sciences, 108(1), 18-31.
45. Hah, Y. S., Jun, J. S., Lee, S. G., et al. (2011). Vascular endothelial growth factor stimulates osteoblastic differentiation of cultured human periosteal-derived cells expressing vascular endothelial growth factor receptors. Molecular Biology Reports, 38(2), 1443-1450.